European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Delphi Genetics Capital Increase One Million Euros to Fund Expansion Programme of GMP Services
Delphi Genetics SA announced today the closing of a capital
increase in excess of 1 Million EUR to support its latest development in
“Good Manufacturing Practices (GMP)” services for protein and DNA
productions, especially engineered for small/medium scale needs. More info >>